Name: UMIN ID:
Unique ID issued by UMIN | C000000136 |
---|---|
Receipt number | R000000202 |
Scientific Title | phase II study of gefitinib as a first-line therapy in elderly patients with lung adenocarcinoma. |
Date of disclosure of the study information | 2005/09/08 |
Last modified on | 2016/09/27 16:32:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/09/08 14:35:09 | ||
2 | Update | 2005/09/08 14:50:06 | Key inclusion criteria Key exclusion criteria |
|
3 | Update | 2008/05/28 10:31:18 | Recruitment status |
|
4 | Update | 2008/05/28 10:33:05 | Name of person sending information Name of person sending information Organization Organization Division name Address TEL Institute Institute Organization Organization Category of Funding Organization |
|
5 | Update | 2015/04/06 10:09:26 | Recruitment status Publication of results |
|
6 | Update | 2015/08/31 15:49:57 | URL related to results and publications |
|
7 | Update | 2016/09/27 16:32:26 | Recruitment status |